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Background: Higher childhood body mass index (BMI) has been associated with an increased risk of 
multiple sclerosis (MS). 
Objective: To evaluate whether childhood BMI has a causal influence on MS, and whether this putative 
effect is independent from early adult obesity and pubertal timing. 
Methods: We performed Mendelian randomization (MR) using summary genetic data on 14,802 MS 
cases and 26,703 controls. Large-scale genome-wide association studies provided estimates for BMI in 
childhood (n=47,541) and adulthood (n=322,154). In multivariable MR, we examined the direct effects 
of each timepoint and further adjusted for age at puberty. Findings were replicated using the UK 
Biobank (n=453,169). 
Results: Higher genetically predicted childhood BMI was associated with increased odds of MS 
(OR=1.26/SD BMI increase, 95%CI 1.07-1.50). However, there was little evidence of a direct effect after 
adjusting for adult BMI (OR=1.03, 95%CI 0.70-1.53). Conversely, the effect of adult BMI persisted 
independent of childhood BMI (OR=1.43; 95%CI 1.01-2.03). The addition of age at puberty did not alter 
the findings. UK Biobank analyses showed consistent results. Sensitivity analyses provided no evidence 
of pleiotropy. 
Conclusion: Genetic evidence supports an association between childhood obesity and MS susceptibility, 




Childhood obesity is a major public health problem, with more than a third of children in the United 
States being either overweight or obese, a trend which continues to increase.1 Recently, observational 
studies have reported that obesity in early adulthood increases the risk of multiple sclerosis (MS).2-6 
While several studies also support a role for childhood obesity in MS,4, 5, 7 some found that this 
association is no longer present following adjustment for obesity at a later life period.2, 6 Understanding 
the role of early life risk factors is particularly important in MS, as the childhood period is a potentially 
critical window for environmental exposures, and potentially, for interventions.8, 9  In addition, obesity is 
associated with a host of factors that can confound the association with the risk of acquiring the disease, 
which limits causal inference from traditional observational epidemiology. 
 
Mendelian randomization (MR) is a strategy that can help address these limitations by harnessing 
natural genetic variation in populations to investigate the causal effect of a risk factor on an outcome.10 
This method greatly reduces confounding since allelic variants influencing different exposures are 
independently segregated and randomly assigned at conception.11 The fact that genotypes are not 
modifiable by disease onset also limits reverse causation.10 Previous MR studies have explored the 
relationship between obesity and MS but have reported on childhood or adult obesity separately.12-15 
Recent developments in MR can be applied to distinguish whether multiple exposures lie within the 
same causal pathway or if they have independent effects on the outcome.16 Specifically, we have 
previously demonstrated the ability of genetic variants to separate between effects for childhood and 
adult body size using a multivariable MR framework.17 
 
In this paper, we apply these methods to assess whether genetic predisposition towards higher 
childhood body mass index (BMI) increases the risk of MS. Then, we explore whether this effect is direct 
 
 
or mediated by the persistence of obesity into early adulthood (Figure 1). Similarly, we estimate the 
direct contribution of early adult obesity and further examine whether these associations are modified 
by pubertal timing. For this, we leveraged large-scale genome-wide association studies (GWAS) of MS, 
childhood and adult BMI (with a similar variance explained by the genetic instruments for both traits). 




Genetic instruments for childhood and adult BMI 
We identified genetic variants associated with childhood BMI using the largest GWAS meta-analysis of 
childhood BMI from the Early Growth Genetics (EGG) consortium, which included 47,541 children aged 
between 2 and 10 years (50.6% males).18 Childhood BMI was calculated based on measured height and 
weight for more than 92% of participants. BMI values were transformed into standard deviation (SD) 
scores and adjusted for age and sex. Thus, the effect size for each allele represents a SD increase in 
childhood BMI, which in turn corresponds to a change in category from normal weight to overweight.1, 19  
To optimize power, we retained 23 single nucleotide polymorphisms (SNPs) that met either of the 
following criteria: (1) genome-wide significance (p-value < 5x10-8) in the joint analysis of the EGG 
consortium GWAS18; or (2) suggestive association (p-value < 5x10-6) with childhood BMI in EGG and 
genome-wide significance for the same variant with comparative body size at age 10 in the UKB 
(n=453,169) (Dataset S1).20 In a secondary analysis, we included only the 15 genome-wide significant 
SNPs satisfying the first criterion. 
 
Effect estimates for adult BMI were obtained from a GWAS meta-analysis by the GIANT Consortium.21 
This included 322,154 individuals (47.1% males). Genetic associations were adjusted for age, age2 and 
 
 
sex, yielding 77 genome-wide significant variants in the European ancestry analysis (Dataset S2). The 
average age of participants was 56 years,21 which is beyond the usual age at MS diagnosis. However, 
previous studies have shown that a genetic risk score for BMI derived from those participants had a 
similar discriminative power in early adulthood (18-25 years) compared to middle adulthood, supporting 
the use of these variants to model early adult obesity in the context of MS (used interchangeably with 
adult obesity herein). For instance, the difference in BMI between the top and bottom fifth of genetic 
susceptibility in a Norwegian cohort was respectively 2.11 and 2.48 kg/m2 for males and females aged 
25, and 1.79 and 2.26 kg/m2 for those aged 55.22 Similar findings were reported in the Cardiovascular 
Risk in Young Finns Study, where the BMI difference between top and bottom genetic risk quartiles was 
approximately 2 kg/m2 throughout early and middle-adulthood (18-49 years).23 Importantly, these 
associations with BMI in early adulthood were replicated in other populations including U.S.24, 25 and 
British26 cohorts. 
 
Genetic instruments for childhood and adult body size in UK Biobank 
Genetic instruments for childhood and adult body size were obtained from our previous GWAS of 
453,169 participants from the UKB.20 Details have been described previously.17 Briefly, our childhood 
measure of body size was based on recall questionnaire data asking individuals ‘When you were 10 
years old, compared to average would you describe yourself as thinner, plumper or about average?’. 
Adult measured BMI (age range 40-69 years) was converted into a categorical variable with 3 groups 
using the same proportions as the early life variable. GWAS were undertaken with adjustment for age, 
sex and genotyping chip using BOLT-LMM. Childhood body size analyses were additionally adjusted for 
month of birth to account for the individuals' relative age within their school year. This analysis yielded 
298 and 557 independent genetic variants for childhood and adult body size respectively (Datasets S3-
4). We previously showed that this childhood body size measure displayed a strong genetic correlation 
 
 
with childhood BMI estimates from the EGG consortium (rg=0.85) and predicted childhood BMI in 
independent cohort (mean age 9.9 years).17 Similarly, the categorical adult body size measure strongly 
correlates with the previous adult BMI effect from GIANT (rg=0.96). 
 
Genetic associations with MS 
The effect estimates for each childhood and adult obesity-related variant on the risk of MS was obtained 
from the discovery cohorts of the latest GWAS meta-analysis by the International MS Genetics 
Consortium (IMSGC).27 This dataset included 14,802 MS cases and 26,703 controls. When a genetic 
instrument for childhood or adult obesity measures was not present in another dataset, we identified a 
proxy SNP in linkage disequilibrium (r2 > 0.6) using PLINK v1.9 and samples of European ancestry from 
1000 Genomes project (Datasets S7-9). All variants were aligned to the forward strand. In the case of 
childhood and adult BMI (not reported on GRCh37), forward strand alleles for palindromic SNPs were 
inferred for allele frequencies up to 0.42. 
 
The presence of correlation between genetic instruments can lead to spurious MR estimates. Therefore, 
we ensured variant pairs were independent (r2 < 0.01). We also excluded variants within the extended 
major histocompatibility complex (MHC) region given that its strong association with MS and complex 
linkage disequilibrium make it susceptible to horizontal pleiotropy (violation of MR assumptions). All 
genetic data were restricted to individuals of European descent to limit population stratification. 
 
Univariable Mendelian randomization 
We performed inverse-variance weighted MR to investigate the total effect of genetically increased 
childhood and adult obesity measures (i.e. BMI and body size) on MS susceptibility, using previously 
described methods.28 A key MR assumption is that the genetic variants associated with the exposure 
 
 
must not affect the outcome through pathways independent of the exposure (horizontal pleiotropy). 
We therefore conducted several sensitivity analyses to test this assumption.29 First, we formally 
examined for overall horizontal pleiotropy using the MR Pleiotropy RESidual Sum and Outlier (MR-
PRESSO) Global test.30 We also applied MR-PRESSO to exclude outlier and thus potentially pleiotropic 
variants. Second, we performed MR-Egger, a weighted linear regression allowing for the intercept to be 
estimated as a measure of average horizontal pleiotropy, as long as the pleiotropic effects are 
independent of the SNP-exposure effects.31 Third, we performed a weighted median analysis, which 
provides robust estimates despite the presence of horizontal pleiotropy in a subset (<50%) of variants.32 
In addition, we inspected funnel plots of the individual MR estimates against their precision, with 
asymmetry indicative of directional horizontal pleiotropy.31 Consistent results across these analyses 
reduce the likelihood of bias.  
 
For the main analysis on childhood BMI, we also assessed whether genetic variants were associated with 
potential confounders by examining them in PhenoScanner,33 a comprehensive database of genotype-
phenotype associations, using a nominal p-value Bonferroni-corrected for the number of variants (p < 
0.05/23=0.00217). Sensitivity analyses excluding variants associated with potential confounders were 
calculated.  
 
To ensure that MR estimates did not suffer from weak instrument bias, we generated F-statistics for 






where 𝛾𝑗  is the SNP-exposure estimate and σXj is the corresponding standard error, and we reported 




Last, to exclude the possibility that biological processes underlying MS influence childhood BMI, 
bidirectional MR was performed using non-HLA variants associated with risk of MS, with childhood BMI 
as the outcome (Dataset S5).  
 
Multivariable Mendelian randomization 
We undertook multivariable MR to estimate the direct effects of childhood and adult obesity measures 
in turn on the risk of MS. Genetic instruments for each trait were included as in the univariable MR, 
after exclusion of outliers. For each variant, effect estimates on both childhood and adult obesity 
measures are included in a weighted multivariable regression model.16 In addition, given the proposed 
role for pubertal timing in MS and its correlation with body weight status,34, 35  we repeated the analysis 
with age at puberty as a third exposure (along with childhood and adult obesity measures) using genetic 
determinants of age at menarche as previously reported (n=329,245).35, 36 The genetic architecture of 
pubertal timing across both sexes is highly correlated (rg=0.75; p=1.2x10-79), allowing these variants to 
provide insight into pubertal timing in males as well. Therefore, they are referred to as age at puberty 
variants. 
 
All statistical analyses were performed in R (version 3.4.1). Statistical significance was set to p<0.05 
unless otherwise specified. The data sources used in this study (IMSGC, EGG consortium, GIANT 




Univariable Mendelian randomization 
 
 
Univariable MR using the 23 childhood BMI-related SNPs showed that each 1-SD increase in childhood 
BMI was associated with 26% higher odds of MS (odds ratio [OR]=1.26, 95% confidence interval [CI] 
1.07-1.50, p-value=0.006).  A secondary analysis using the restricted set of 15 genome-wide significant 
SNPs yielded consistent results (OR=1.23, 95%CI 1.05-1.43, p-value=0.01). In PhenoScanner,33 we 
identified associations with potential confounders between rs13387838 and smoking initiation 
(p=0.002), rs25832 and generalized epilepsies (p=1.02x10-6), as well as between two variants and the 
number of years of schooling completed (rs13107325, p=0.002; rs7869969, p=5.3x10-6). Exclusion of 
these four variants had no influence on the results (OR=1.29, 95%CI 1.12-1.49, p-value=0.0006). All 
observed SNP-phenotype associations are listed in Dataset S10; none were found for other reported MS 
risk factors including vitamin D levels, sun exposure, EBV or CMV infection, oral tobacco or organic 
solvent exposure. Similar findings were replicated using 277 childhood body size-related variants from 
the UKB (OR=1.40/change in body size category, 95%CI 1.10-1.78, p-value=0.01) (Dataset S3).  
 
These results were robust to sensitivity analyses for pleiotropy in both the EGG childhood BMI and UKB 
childhood body size analyses (Figure 2). The MR-PRESSO global test showed no evidence of pleiotropy 
for the EGG childhood BMI analysis (p-value=0.093). In the larger UKB childhood body size analysis, the 
MR-PRESSO global test was significant (p-value<2x10-5) yet the MR estimate after excluding 8 outlier 
variants (Dataset S3) remained largely unchanged (OR=1.38, 95%CI 1.09-1.76, p-value=0.008). The MR-
Egger intercept was centered around zero (EGG childhood BMI: intercept=-0.020, 95%CI -0.052-0.012, p-
value=0.22; UKB childhood body size: intercept=-0.001, 95%CI -0.008-0.006, p-value=0.72). The MR-
Egger and weighted median estimates were consistent with the main finding (Figure 2). Funnel plots 
were found to be approximately symmetric (Figure 3). Using 188 non-MHC MS-related SNPs (Dataset 
S5), we found no evidence that genetically increased MS susceptibility influenced childhood BMI 




Evaluating the effect of adult BMI on the risk of MS, univariate MR using 74 variants revealed a 40% 
increase in the odds of MS per 1-SD increase in BMI (OR=1.40, 95%CI 1.17-1.67, p=3.1x10-4). The 522 
genetic determinants of adult body size in the UKB identified a concordant association (OR=1.52/change 
in body size category, 95%CI 1.29-1.80, p-value=8.2x10-7) 
 
The mean F-statistics for obesity measures were all greater than 10, suggesting adequately strong 
instruments (childhood BMI: 45.2, adult BMI: 67.3, childhood body size: 66.9, adult body size: 52.0). 
 
Multivariable Mendelian randomization 
The direct effect of childhood obesity measures on the risk of MS was notably weaker compared to the 
total effect reported in the univariable analyses (Figure 4). For childhood BMI, this direct effect (not 
mediated by adult BMI) was essentially null (OR=1.03, 95%CI 0.70-1.53, p-value=0.88). UKB childhood 
body size estimates similarly found evidence against a direct effect on MS (OR=1.05, 95%CI 0.64-1.73, p-
value=0.84). The addition of age at puberty to the model did not alter the results (EGG childhood BMI: 
OR=1.10, 95%CI 0.68-1.78, p-value=0.70; UKB childhood body size: OR=1.02, 95%CI 0.59-1.74, p-
value=0.95). In contrast, direct effect estimates for adult obesity measures remained robust and 
consistent with the total effects (Figure 4; GIANT adult BMI: OR=1.43; 95%CI 1.01-2.03, p-value=0.04; 
UKB adult body size: OR=1.75, 95%CI 1.35-2.27, p-value=2.1x10-5). Inclusion of age at puberty did also 
not affect the estimates (adult BMI: OR=1.54, 95%CI 1.07-2.21, p-value=0.02; adult body size: OR=1.75, 







This study examined the relative contribution of childhood and early adult obesity on the risk of MS 
using an MR framework. The results provide genetic support for a total causal effect of childhood 
obesity on MS susceptibility, albeit indirectly through persistence of larger body size in early adulthood. 
Indeed, when analyzed together with adult obesity measures, the contribution of childhood obesity was 
considerably attenuated and compatible with a null effect. In contrast, the association between adult 
obesity measures and MS remained unchanged after adjusting for childhood obesity measures, implying 
a direct effect on the risk of disease. Similar findings were obtained with both BMI measures and body 
size categories from independent cohorts, with the differences in effect sizes explained by the different 
scales (SD increase for BMI vs. change in body size category). We conducted several sensitivity analyses 
which found little evidence of genetic pleiotropy, adding further robustness to the findings. We have 
also shown that biological mechanisms underlying MS susceptibly do not have a large influence obesity 
measures. In addition, the inclusion of pubertal timing in multivariable MR did not influence the results, 
indicating that it does not lie within the causal pathway between obesity and MS risk. The finding 
corroborates our previous study showing that age at puberty does not exert independent effects on MS 
risk, but this does not eliminate the possibility that puberty attainment (rather its timing) may still play a 
key role in MS onset.36 
 
These findings support previous observational studies that have examined the role of childhood obesity 
in MS. A prospective study reported a hazard ratio for MS of 1.15 to 1.18 per unit increase in BMI z-
score measured between ages 7 and 13.7 This was replicated in different populations using self-reported 
weight status.4, 5 Those studies did not account for possible effects of obesity in later life. A study 
including women from two US cohorts reported a possible increased risk of MS with larger childhood 
body size at ages 5 and 10 using recalled silhouettes, however this association was no longer present 
 
 
after adjusting for body size at age 20.2 Conversely, larger body size at age 20 remained associated with 
MS despite adjustment for earlier time points. A case-control study similarly found that BMI at age 20, 
but not body size at age 10, was independently associated with MS risk.6 Together with these 
observational findings, our results argue against a persistent effect of childhood obesity. 
 
Previous MR studies have explored the relationship between obesity and MS but did not distinguish 
between childhood and adult time periods.12-14, 37 Interestingly, our estimates for the total effect of adult 
BMI agree exactly with those from an earlier study using an independent MS susceptibility GWAS 
(OR=1.41, 95%CI 1.20-1.66).13 Another MR study found no association between pediatric MS and an 
unweighted genetic risk score of 28 variants for childhood BMI,37 although this could be attributable to 
the smaller sample size compared to the present study (569 vs. 14,802 cases) and the inclusion of 
weakly associated variants. More recent work reported a similar effect for childhood BMI on MS using 
the EGG consortium estimates, but did not account for adult obesity.14  
 
The mechanisms by which obesity contributes to the etiology of MS are largely unknown. Proposed 
mechanisms include reduced circulating vitamin D levels and chronic inflammation secondary to 
increased adiposity.15 In addition, higher BMI has also been shown to interact with environmental and 
genetic factors to increase risk of MS, namely EBV infection38 and HLA-DRB1*15 status.39 
 
An important strength of this study is the application of a two-sample MR approach which minimizes the 
risk of bias from confounding and allowed us to leverage large-scale genetic data on childhood and adult 
obesity measures as well as MS. Furthermore, we provide replication of our results using the UKB 
resource (n=453,169). We also build on recent methodological developments in multivariable MR to 
investigate time-dependent effects, an approach which may prove useful in other neurological 
 
 
conditions. Nonetheless, we acknowledge a number of limitations. We cannot completely exclude the 
possibility of horizontal pleiotropy, which could bias the reported estimates. However, our sensitivity 
analyses included a range of methods that yielded generally consistent results. In selecting our genetic 
instruments for the EGG childhood BMI analysis, we included 8 variants that showed a suggestive 
association (p-value < 5x10-6) but were not genome-wide significant. This was justified by the gain in 
power and validated by their genome-wide significant association with body size at age 10 in the larger 
UKB. Repeating the analysis with only the 15 SNPs genome-wide significant in EGG resulted in similar 
point estimates across the various analyses. In addition, the inclusion of weak instruments in two-
sample MR would be expected to drive the association towards the null. The imbalance in sample size 
between the EGG childhood BMI cohort (N=47,541) and GIANT adult BMI cohort (N=322,154) could 
have led to incomplete adjustment for childhood effects in multivariable MR. However, this possibility is 
lessened by the fact that both genetic instruments explained a similar variance in their respective traits 
(2.7% for childhood BMI and 2.3% for adult BMI). Moreover, the UKB analysis included the same number 
of individuals for both exposures. The adult BMI genetic estimates were derived from GWAS in middle-
aged individuals older than the average age at MS onset. While subsequent studies support their 
influence over BMI in early adulthood, additional work is needed to better characterize age- and period-
specific genetic effects using longitudinal measures and BMI trajectories throughout childhood, 
adolescence and adulthood. This study was restricted to individuals of European descent to prevent 
population stratification and therefore our findings have limited generalizability to other ancestral 
populations. European ancestry individuals were chosen because most GWAS data arises from 
individuals of this ancestry. This underlines the importance of on-going efforts to conduct GWAS in 
individuals of non-European ancestry. Last, the use of summary statistics precluded sex-stratified 
analyses as such genetic data sets are not currently available for MS. Reassuringly, previous cohort and 
 
 
case-control studies have found no difference between MS risk and childhood or early adult obesity in 
males and females, although lower sample size for men generally led to reduced power.6, 7 
 
In conclusion, this study provides genetic evidence supporting a role for childhood and early adult 
obesity in the development of MS. Importantly, our results also suggest that the effects of childhood 
obesity on MS are mediated by persistence of obesity into early adulthood, but independent of pubertal 
timing. These findings may help counsel individuals at high risk of MS and inform prevention strategies. 
Further investigation is required to better understand the biological mechanisms by which obesity 
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Figure 1. Directed acyclic graph of the possible pathways linking childhood obesity to MS susceptibility 
in a multivariable MR framework. Childhood obesity could influence the risk of MS directly (blue 
arrow), indirectly via persistence of obesity into early adulthood (orange arrow), or a combination 
thereof. In contrast, under a causal model, the total effect of early adult obesity should be equivalent to 
its direct effect (dotted line). 
BMI = body mass index; MS = multiple sclerosis; SNP = single nucleotide polymorphism 
 
Figure 2. Forest plot showing the univariable MR estimates investigating the total effect of childhood 
obesity measures on MS. There were no MR-PRESSO outlier variants identified in the EGG childhood 
BMI analysis. aOdds ratios for MS are reported per standard deviation increase in BMI. bOdds ratios for 
MS are reported per change in body size category. 
BMI=body mass index; CI=confidence intervals; EGG=Early Growth Genetics; MR=Mendelian 
randomization; NSNPs=number of variants in the analysis; OR=Odds ratio; SNP=single nucleotide 
polymorphism; UKB=UK Biobank. 
 
Figure 3. Funnel plots of the individual MR estimates against their precision for the effect on MS of (A) 
childhood BMI and (B) childhood body size.  
BMI=body mass index; EGG=Early Growth Genetics; IVW=inverse-variance weighted; MR=Mendelian 





Figure 4. Forest plot illustrating the total and direct effects of childhood and adult obesity measures 
on MS. Effects from univariable MR are post outlier removal when applicable. aOdds ratios for MS are 
reported per standard deviation increase in BMI. bOdds ratios for MS are reported per change in body 
size category. 
BMI=body mass index; CI=confidence intervals; EGG=Early Growth Genetics; MR=Mendelian 
randomization; NSNPs=number of variants in the analysis; OR=Odds ratio; SNP=single nucleotide 
polymorphism; UKB=UK Biobank. 
